Local, Quantitative Morphometry of Fibroproliferative Lung Injury using Laminin

por Cox, Brendan P., Hannan, Riley T., Batrash, Noora, Sturek, Jeffrey M.
Publicado 2023

Evaluation of K18-hACE2 Mice as a Model of SARS-CoV-2 Infection

por Moreau, Gregory Brett, Burgess, Stacey L., Sturek, Jeffrey M., Donlan, Alexandra N., Petri, William A., Mann, Barbara J.
Publicado 2020

COVID-19 patients exhibit unique transcriptional signatures indicative of disease severity

por Daamen, Andrea R., Bachali, Prathyusha, Bonham, Catherine A., Somerville, Lindsay, Sturek, Jeffrey M., Grammer, Amrie C., Kadl, Alexandra, Lipsky, Peter E.
Publicado 2022

Improved survival of SARS COV-2-infected K18-hACE2 mice treated with adenosine A(2A)R agonist()

por Mann, Barbara J., Chhabra, Preeti, Ma, Mingyang, Brovero, Savannah G., Hannan, Riley T., Sturek, Jeffrey M., Jones, Marieke K., Linden, Joel, Brayman, Kenneth L.
Publicado 2023

Discrete T-Cell and Inflammatory Profiles in the Blood Define Pulmonary Phenotypes After COVID-19 Illness.

por Canderan, Glenda, Muehling, Lyndsey, Kadl, Alexandra, Sturek, Jeffrey, Bonham, Catherine, Murphy, Deborah, Barone, Sierra, Cross, Claire, Cheon, In Su, Sun, Jie, Jonathan irish, Woodfolk, Judith
Publicado 2023

Survivors Of Severe COVID-19 With Long-Haul Respiratory Symptoms Display Enhanced Activation of Circulating T Cells

por Canderan, Glenda, Muehling, Lyndsey, Kadl, Alexandra, Ramani, Chintan, Sturek, Jeffrey, Bonham, Cathy, Murphy, Deborah, Wright, Paul, Keshavarz, Behnam, Wilson, Jeffrey, Barone, Sierra, Irish, Jonathan, Woodfolk, Judith
Publicado 2022

Pulmonary function and survival one year after dupilumab treatment of acute moderate to severe COVID-19: A follow up study from a Phase IIa trial

por Hendrick, Jennifer, Ma, Jennie Z., Haughey, Heather M., Coleman, Rachael, Nayak, Uma, Kadl, Alexandra, Sturek, Jeffrey M., Jackson, Patrick, Young, Mary K., Allen, Judith E., Petri, William A.
Publicado 2023

Development of COVID-19 vaccine using a dual Toll-like receptor ligand liposome adjuvant

por Abhyankar, Mayuresh M., Mann, Barbara J., Sturek, Jeffrey M., Brovero, Savannah, Moreau, G. Brett, Sengar, Anjali, Richardson, Crystal M., Agah, Sayeh, Pomés, Anna, Kasson, Peter M., Tomai, Mark A., Fox, Christopher B., Petri, William A.
Publicado 2021

Safety and Efficacy of Dupilumab for the Treatment of Hospitalized Patients with Moderate to Severe COVID 19: A Phase IIa Trial

por Sasson, Jennifer, Donlan, Alexandra N., Ma, Jennie Z., Haughey, Heather M., Coleman, Rachael, Nayak, Uma, Mathers, Amy J., Laverdure, Sylvain, Dewar, Robin, Jackson, Patrick E. H., Heysell, Scott K., Sturek, Jeffrey M., Petri, William A.
Publicado 2022

Safety and Efficacy of Dupilumab for the Treatment of Hospitalized Patients With Moderate to Severe Coronavirus Disease 2019: A Phase 2a Trial

por Sasson, Jennifer, Donlan, Alexandra N, Ma, Jennie Z, Haughey, Heather M, Coleman, Rachael, Nayak, Uma, Mathers, Amy J, Laverdure, Sylvain, Dewar, Robin, Jackson, Patrick E H, Heysell, Scott K, Sturek, Jeffrey M, Petri, William A
Publicado 2022

(18)F-NaF and (18)F-FDG as molecular probes in the evaluation of atherosclerosis

por McKenney-Drake, Mikaela L., Moghbel, Mateen C., Paydary, Koosha, Alloosh, Mouhamad, Houshmand, Sina, Moe, Sharon, Salavati, Ali, Sturek, Jeffrey M., Territo, Paul R., Weaver, Connie, Werner, Thomas J., Høilund-Carlsen, Poul Flemming, Sturek, Michael, Alavi, Abass
Publicado 2018

Inhibition of the mitochondrial pyruvate carrier simultaneously mitigates hyperinflammation and hyperglycemia in COVID-19

por Zhu, Bibo, Wei, Xiaoqin, Narasimhan, Harish, Qian, Wei, Zhang, Ruixuan, Cheon, In Su, Wu, Yue, Li, Chaofan, Jones, Russell G., Kaplan, Mark H., Vassallo, Robert A., Braciale, Thomas J., Somerville, Lindsay, Colca, Jerry R., Pandey, Akhilesh, Jackson, Patrick E. H., Mann, Barbara J., Krawczyk, Connie M., Sturek, Jeffrey M., Sun, Jie
Publicado 2023

Convalescent Plasma for Preventing Critical Illness in COVID-19: a Phase 2 Trial and Immune Profile

por Sturek, Jeffrey M., Thomas, Tania A., Gorham, James D., Sheppard, Chelsea A., Raymond, Allison H., Petros De Guex, Kristen, Harrington, William B., Barros, Andrew J., Madden, Gregory R., Alkabab, Yosra M., Lu, David Y., Liu, Qin, Poulter, Melinda D., Mathers, Amy J., Thakur, Archana, Schalk, Dana L., Kubicka, Ewa M., Lum, Lawrence G., Heysell, Scott K.
Publicado 2022

Proximal immune-epithelial progenitor interactions drive chronic tissue sequelae post COVID-19

por Narasimhan, Harish, Cheon, In Su, Qian, Wei, Hu, Sheng’en, Parimon, Tanyalak, Li, Chaofan, Goplen, Nick, Wu, Yue, Wei, Xiaoqin, Son, Young Min, Fink, Elizabeth, Santos, Gislane, Tang, Jinyi, Yao, Changfu, Muehling, Lyndsey, Canderan, Glenda, Kadl, Alexandra, Cannon, Abigail, Young, Samuel, Hannan, Riley, Bingham, Grace, Arish, Mohammed, Chaudhari, Arka Sen, Sturek, Jeffrey, Pramoonjago, Patcharin, Shim, Yun Michael, Woodfolk, Judith, Zang, Chongzhi, Chen, Peter, Sun, Jie
Publicado 2023

IL-13 is a driver of COVID-19 severity

por Donlan, Alexandra N., Sutherland, Tara E., Marie, Chelsea, Preissner, Saskia, Bradley, Ben T., Carpenter, Rebecca M., Sturek, Jeffrey M., Ma, Jennie Z., Moreau, G. Brett, Donowitz, Jeffrey R., Buck, Gregory A., Serrano, Myrna G., Burgess, Stacey L., Abhyankar, Mayuresh M., Mura, Cameron, Bourne, Philip E., Preissner, Robert, Young, Mary K., Lyons, Genevieve R., Loomba, Johanna J., Ratcliffe, Sarah J, Poulter, Melinda D., Mathers, Amy J., Day, Anthony, Mann, Barbara J., Allen, Judith E., Petri, William A.
Publicado 2021

IL-13 is a driver of COVID-19 severity

por Donlan, Alexandra N., Sutherland, Tara E., Marie, Chelsea, Preissner, Saskia, Bradley, Benjamin T., Carpenter, Rebecca M., Sturek, Jeffrey M., Ma, Jennie Z., Moreau, G. Brett, Donowitz, Jeffrey R., Buck, Gregory A., Serrano, Myrna G., Burgess, Stacey L., Abhyankar, Mayuresh M., Mura, Cameron, Bourne, Philip E., Preissner, Robert, Young, Mary K., Lyons, Genevieve R., Loomba, Johanna J., Ratcliffe, Sarah J., Poulter, Melinda D., Mathers, Amy J., Day, Anthony J., Mann, Barbara J., Allen, Judith E., Petri, William A.
Publicado 2021